Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

936
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
936
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.4K
Prodrugs01:30

Prodrugs

3.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scalable Inference-Time Annealing with Surrogate Likelihood Estimators.

ArXiv·2026
Same author

GEOM-drugs revisited: toward more chemically accurate benchmarks for 3D molecule generation.

Digital discovery·2025
Same author

BoltzNCE: Learning Likelihoods for Boltzmann Generation with Stochastic Interpolants and Noise Contrastive Estimation.

ArXiv·2025
Same author

PharmacoForge: pharmacophore generation with diffusion models.

Frontiers in bioinformatics·2025
Same author

GNINA 1.3: the next increment in molecular docking with deep learning.

Journal of cheminformatics·2025
Same author

CACHE Challenge #1: Docking with GNINA Is All You Need.

Journal of chemical information and modeling·2024
Same journal

Scalable Molecular Dynamics with NAMD on the Summit System.

IBM journal of research and development·2020
Same journal

An interpretable health behavioral intervention policy for mobile device users.

IBM journal of research and development·2018
Same journal

Evolutionary algorithm optimization of biological learning parameters in a biomimetic neuroprosthesis.

IBM journal of research and development·2017
See all related articles

Related Experiment Video

Updated: Nov 8, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K

The Pharmit Backend: A Computer Systems Approach to Enabling Interactive Online Drug Discovery.

David Ryan Koes1

  • 1University of Pittsburgh, Pittsburgh, PA 15260, USA.

IBM Journal of Research and Development
|April 19, 2021
PubMed
Summary
This summary is machine-generated.

Pharmit is an open-source online tool for structure-based drug discovery. Its system design and novel algorithms enable rapid screening of millions of compounds in seconds.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.3K
The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble
06:50

The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble

Published on: June 5, 2021

3.8K

Related Experiment Videos

Last Updated: Nov 8, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.9K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.3K
The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble
06:50

The Automated Crystallography Pipelines at the EMBL HTX Facility in Grenoble

Published on: June 5, 2021

3.8K

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Drug discovery

Background:

  • Structure-based drug discovery workflows require efficient searching of large compound libraries.
  • Existing methods may face limitations in speed and scalability when handling millions of molecules.

Purpose of the Study:

  • To describe the system-level implementation of Pharmit, an open-source online resource for drug discovery.
  • To detail the novel algorithms enabling rapid screening of large compound libraries.

Main Methods:

  • Pharmit utilizes a system design focused on maximizing parallelism and minimizing communication.
  • Optimized data layout for sequential processing and efficient memory management are key.
  • Sub-linear time search algorithms are employed for rapid molecule screening.

Main Results:

  • Pharmit enables interactive searching of millions of compounds.
  • The system successfully screens millions of molecules in seconds.
  • The implementation demonstrates efficient handling of cheminformatic data.

Conclusions:

  • Pharmit's system design and algorithms provide a scalable solution for structure-based drug discovery.
  • The resource facilitates rapid identification of potential drug candidates.
  • Future directions may involve further optimization and expansion of capabilities.